Brief: Proqr Announces Axiomer RNA Editing Licensing And Research Collaboration With Lilly

ProQR Therapeutics NV

08/09/2021 21:13

Sept 8 (Reuters) - ProQR Therapeutics NV  PRQR.O :
    * PROQR ANNOUNCES AXIOMER® RNA EDITING LICENSING AND
RESEARCH
COLLABORATION WITH LILLY
    * PROQR THERAPEUTICS - COS TO COLLABORATE TO DEVELOP EDITING
OLIGONUCLEOTIDES DIRECTED TO UP TO FIVE TARGETS USING CO'S
AXIOMER RNA EDITING PLATFORM
    * PROQR THERAPEUTICS NV - TO RECEIVE $50 MILLION CONSISTING
OF
UPFRONT PAYMENT AND EQUITY INVESTMENT
    * PROQR THERAPEUTICS - ELIGIBLE TO ADDITIONALLY RECEIVE UP
TO
ABOUT $1.25 BILLION IN RESEARCH, DEVELOPMENT, COMMERCIALIZATION
MILESTONES, PLUS ROYALTIES

Source text for Eikon:  ID:nGNEcdFQgm 
Further company coverage:  PRQR.O 

 ((Reuters.Briefs@thomsonreuters.com;))